VAG
RETA

VisionPoint Advisory Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

VisionPoint Advisory Group’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-403
Closed -$41.1K – 843
2023
Q2 		$41.1K Buy
+403
New +$41.1K 0.02% 228